Bipolar disorder and the endocannabinoid system: a possible theoretical framework to prime a brand-new ammo for the management of bipolar disorder

• In: Poster Presentation
• At: Stockholm (Sweden) (2017)
• Type: Poster
• Poster code: P-E-004-Monday
• By: BEHZADI, Mina (Kerman university of Medical sciences, Medicine, Kerman, Iran, Islamic Republic Of)
• Co-author(s): Mina Behzadi: Neuroscience Research Center, Neuropharmacology Institute, Kerman, Iran, Islamic Republic Of
  Shokouh Arjmand: Neuroscience Research Center, Neuropharmacology Institute, Kerman, Iran, Islamic Republic Of
  Mohammad Shabani: Neuroscience Research Center, Neuropharmacology Institute, Kerman, Iran, Islamic Republic Of
  Sara Ezzatabadipour: Neuroscience Research Center, Neuropharmacology Institute, Kerman, Iran, Islamic Republic Of
  
• Abstract:

  Backgrounds

  Oscillatory mood states, swinging from (hypo)mania to depression, each leaving their own aftermaths makes bipolar disorder (BD) among debilitating lifelong neuropsychiatric illnesses. Despite holding a wide range of ammunition in our arsenal to ameliorate the acute affective symptoms and prevent episodic relapse, BD is sometimes..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login